Net income · 2020–2025

Starling Oncology net income

$60.6M−6.3% · FY2025

Starling Oncology (STLN) reported $60.6M in net income for fiscal 2025, −6.3% year on year.

−$14.3M2020−$10.9M2021$152,0002022−$83.1M2023$64.7M2024$60.6M2025
Starling Oncology — Net income, 2020–2025
Fiscal yearNet incomeChangeFiling
FY20252025-12-31$60.6M−6.3%Open →Scale corrected ÷10³
FY20242024-12-31$64.7M+$148MOpen →Scale corrected ÷10³
FY20232023-12-31−$83.1M−$83.2MOpen →
FY20222022-12-31$152,000+$11.1MOpen →
FY20212021-12-31−$10.9M+$3.4MOpen →
FY20202020-12-31−$14.3M—Open →

Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Net income at companies of similar size

Full ranking by net income →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Starling Oncology net income |url=https://companiesranked.com/en/company/starling-oncology/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Starling Oncology net income. CompaniesRanked. https://companiesranked.com/en/company/starling-oncology/net-income

BibTeX

@misc{companiesranked-en-company-starling-oncology-net-income-2026,
  author       = {{CompaniesRanked}},
  title        = {{Starling Oncology net income}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/starling-oncology/net-income}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Starling Oncology overview